- $154.99m
- $173.66m
- $70.53m
Edap Tms SA expected to post a loss of 10 cents a share - Earnings Preview
Brief: EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
Edap Tms SA reports results for the quarter ended in September 30 - Earnings Summary
Edap Tms SA expected to post a loss of 15 cents a share - Earnings Preview
Edap Tms SA reports results for the quarter ended in June - Earnings Summary
Edap Tms SA expected to post a loss of 12 cents a share - Earnings Preview
Brief: EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
Edap Tms SA expected to post a loss of 11 cents a share - Earnings Preview
Brief: Edap Tms SA Files For Mixed Shelf Of Upto Us$125 Million - SEC Filing
Edap Tms SA reports results for the quarter ended in December - Earnings Summary
Edap Tms SA expected to post a loss of 4 cents a share - Earnings Preview
Brief: EDAP TMS S.A. Q4 revenue EUR 19.6 million
Brief: Edap Announces Completion Of Enrollment In Phase 3 Study
Brief: EDAP Reports Prelim Q4 Record Focal One System Sales and Placements
Brief: EDAP Announces Positive Opinion For Reimbursement From The French National Authority For Health For HIFU Treatment Of Prostate Cancer
Brief: EDAP TMS S.A. Q3 basic EPS EUR -0.11
Edap Tms SA reports results for the quarter ended in June - Earnings Summary
Edap Tms SA expected to post a loss of 5 cents a share - Earnings Preview
Brief: EDAP Announces Reimbursement Approval In Switzerland For Use Of High-Intensity Focused Ultrasound In Treatment Of Prostate Cancer